Search Results - "McDonnell, G V"

Refine Results
  1. 1

    Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors by Hawkins, S A, McDonnell, G V

    “…OBJECTIVE To establish the characteristics of patients following a benign course of multiple sclerosis and evaluate the importance of potential prognostic…”
    Get full text
    Journal Article Conference Proceeding
  2. 2
  3. 3

    Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study by Gray, OM, McDonnell, GV, Hawkins, SA

    Published in Multiple sclerosis (01-01-2009)
    “…Objective To investigate the psychometric properties of the Multiple Sclerosis Impact Scale (MSIS-29) and to assess the relationship between the Kurtzke…”
    Get full text
    Journal Article
  4. 4

    Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland by Gray, OM, McDonnell, GV, Hawkins, SA

    Published in Multiple sclerosis (01-08-2008)
    “…Background Northern Ireland is recognized as an area of high risk for multiple sclerosis. The original study of Allison and Millar in 1951 found a prevalence…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Transient cardiomyopathy as the presenting feature of acute disseminated encephalomyelitis by Mawhinney, E., Watt, M., McDonnell, GV

    Published in Multiple sclerosis (01-12-2009)
    “…Brainstem lesions are rarely associated with neurogenic pulmonary oedema (NPO) in multiple sclerosis and other disorders. The exact mechanism for this is…”
    Get full text
    Journal Article
  7. 7

    Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae by Kerr, J R, Barah, F, Chiswick, M L, McDonnell, G V, Smith, J, Chapman, M D, Bingham, J B, Kelleher, P, Sheppard, M N

    “…Objective: To review the clinical and pathological features of parvovirus B19 meningoencephalitis and its sequelae in 12 previously published cases, and to…”
    Get full text
    Journal Article
  8. 8
  9. 9

    An epidemiologic study of multiple sclerosis in Northern Ireland by MCDONNELL, G. V, HAWKINS, S. A

    Published in Neurology (01-02-1998)
    “…We wanted to establish the point prevalence of MS in Northern Ireland. Northern Ireland has been a known high-risk area for MS since the original work of…”
    Get full text
    Journal Article
  10. 10

    Issues of medical management in adults with spina bifida by MCDONNELL, G. V, MCCANN, J. P

    Published in Child's nervous system (01-04-2000)
    “…The objective of this study was to establish the range of medical issues among those attending a clinic for adults with spina bifida (SB) and hydrocephalus…”
    Get full text
    Journal Article
  11. 11

    A systematic review of oral methotrexate for multiple sclerosis by Gray, O M, McDonnell, G V, Forbes, R B

    Published in Multiple sclerosis (01-08-2006)
    “…Oral methotrexate is a potent immunosuppressant, which could have a beneficial effect on relapse rates and delay disease progression in multiple sclerosis…”
    Get full text
    Journal Article
  12. 12

    Primary progressive multiple sclerosis: increasing clarity but many unanswered questions by McDonnell, G.V, Hawkins, S.A

    Published in Journal of the Neurological Sciences (15-07-2002)
    “…Heterogeneity in the clinical course of multiple sclerosis (MS) is well recognised and patients following a primary progressive course, 10–15% of the MS…”
    Get full text
    Book Review Journal Article
  13. 13

    An investigation of susceptibility loci in benign, aggressive and primary progressive multiple sclerosis in Northern Irish population by Gray, OM, Abdeen, H, McDonnell, GV, Patterson, CC, Graham, CA, Hawkins, SA

    Published in Multiple sclerosis (01-03-2009)
    “…Objective To investigate the possibility that susceptibility loci in multiple sclerosis (MS) have a role in determining the disease outcome in Northern Ireland…”
    Get full text
    Journal Article
  14. 14

    Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK by McDonnell, G V, Hawkins, S A

    “…OBJECTIVE To investigate the clinical and demographic characteristics of primary progressive multiple sclerosis (PPMS) in Northern Ireland and to establish a…”
    Get full text
    Journal Article
  15. 15

    Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: The subclinical stage of primary progressive multiple sclerosis may last 10 years by McDonnell, G V, Cabrera-Gomez, J, Calne, D B, Li, D KB, Oger, J

    Published in Multiple sclerosis (01-03-2003)
    “…Background: Subclinical multiple sclerosis (MS) has been identified incidentally at autopsy; apparently unaffected individuals with an affected twin have…”
    Get full text
    Journal Article
  16. 16

    A study of the HLA-DR region in clinical subgroups of multiple sclerosis and its influence on prognosis by McDonnell, G.V., Mawhinney, H., Graham, C.A., Hawkins, S.A., Middleton, D.

    Published in Journal of the neurological sciences (01-05-1999)
    “…Objective: To investigate the HLA-DR associations in relapsing-remitting/secondary progressive multiple sclerosis (RR/SPMS) and primary progressive MS (PPMS)…”
    Get full text
    Journal Article
  17. 17

    094  Measuring neutralising antibodies (NAbs) to interferon-beta (IFNB) for multiple sclerosis (MS): a neglected practice? by McKee, JD, Spence, RW, Hughes, S, Gray, O, Campbell, J, Droogan, A, McDonnell, GV

    “…ObjectiveTo determine frequency of testing for NAbs to IFNB in our MS population and adherence to international (EFNS) guidelines.BackgroundIFNB was the first…”
    Get full text
    Journal Article
  18. 18

    An assessment of the spectrum of disability and handicap in multiple sclerosis: a population-based study by McDonnell, G.V., Hawkins, S.A.

    Published in Multiple sclerosis (01-04-2001)
    “…To establish the spectrum of disability and handicap in a population based sample of multiple sclerosis (MS) patients. Much knowledge exists about the…”
    Get full text
    Journal Article
  19. 19

    Serum soluble adhesion molecules in multiple sclerosis : raised sVCAM-1, sICAM-1 and sE-selectin in primary progressive disease by MCDONNELL, G. V, MCMILLAN, S. A, DOUGLAS, J. P, DROOGAN, A. G, HAWKINS, S. A

    Published in Journal of neurology (01-02-1999)
    “…Leucocyte invasion into the central nervous system in multiple sclerosis (MS) is complex, involving T-cell/endothelium interaction dependent upon initial…”
    Get full text
    Journal Article
  20. 20

    An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis by McDonnell, G.V, Kirk, C.W, Hawkins, S.A, Graham, C.A

    Published in Journal of the neurological sciences (01-05-2000)
    “…Differential expression of interleukins may influence susceptibility to inflammatory diseases such as MS. IL-1a production is increased in MS patients during…”
    Get full text
    Journal Article